Khosro Hekmat | OMICS International

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Khosro Hekmat


Pn1 Involvement Independently Affects Long-Term Survival of Pn2 StageNon-Small Cell Lung Cancer after Thoracic Surgery

Background: Lung cancer remains the most common cause of cancer death worldwide. Anatomical lung resection remains the standard in early-stage lung cancer, but the ideal therapy for advance-stage Non-Small Cell Lung Cancer (NSCLC) with pN2 lymph node involvement remains controversial. In most cases pN1 and pN2 lymph nodes are affected consecutively... Read More»

Georg Schlachtenberger, Fabian Doerr, Hruy Menghesha, Matthias B. Heldwein, Maximilian Michel, Thorsten Wahlers and Khosro Hekmat

: J Oncol Res Treat

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article